RESUMO
The present research studied the cytotoxicity, antioxidant, and antidiabetic activities of biogenically synthesized silver nanoparticles (AgNPs) using Ziziphora clinopodioides (Z. clinopodioides) as a green mediator. Scanning electron microscopy (SEM), transmission electron microscopy (TEM), and ultraviolet-visible spectroscopy (UV-Vis) were employed to determine AgNPs. In the in vivo experiment, the model rats were categorized into different groups receiving 50, 100, 200, and 400 µg/kg of AgNPs and diabetic, positive, and normal groups (n = 10) using a random division. A single dose of streptozotocin (STZ) at 60 mg/kg was administered to induce diabetes and hepatotoxicity in rats. The administration of AgNPs was performed via intragastric administration for 25 days. On the final day, the levels of glucose and biochemical enzymes, namely aspartate aminotransferase (AST), alkaline phosphatase (ALP), alanine transaminase (ALT), and gamma-glutamyltransferase (GGT), were assessed in the serum. Following tissue processing, liver sections with a thickness of 5 µm were prepared. Later, the total volume of different liver components, such as hepatocytes, sinusoids, portal vein, central vein, hepatic arteries, and bile ducts, was measured. The portal vein and bile duct volumes did not vary significantly in groups treated by AgNPs. However, the volume of the central vein and hepatic arteries exhibited noticeable variations in groups treated by AgNPs. After administration of streptozotocin, the volume of hepatocytes and sinusoids increased significantly. However, treatment with a high dose of AgNPs significantly decreased the volume of hepatocytes and sinusoids. In diabetic rats, administering AgNPs reduced the fasting blood glucose levels compared to the model group. In addition, AgNPs decreased the elevated levels of AST and ALP enzymes in a manner that depended on the dosage of AgNPs used. This research demonstrates the hepatoprotective and antidiabetic properties of AgNPs, suggesting their potential implications as hepatoprotective and antidiabetic supplements to prevent diabetes.
RESUMO
The purpose of the recent research was to assess the chemical characterization and antioxidant, cytotoxic, antibacterial, and antifungal effects of Allium Saralicum R.M. Fritsch leaves. After identification of the plant, its ethanolic extract was obtained using Soxhlet extractor without leaving any chemicals in it. Gas chromatography-mass spectrometry (GC/MS) was performed to detect the percentage, retention index, and time of A. Saralicum compounds. Agar diffusion tests were applied to determine the antibacterial and antifungal characteristics. In agar disk diffusion test, dimethyl sulfoxide (DMSO) was used as negative control, while antibacterial (Difloxacin, Chloramphenicol, Streptomycin, Gentamicin, Oxytetracycline, Ampicillin, and Amikacin) and antifungal (Fluconazole, Itraconazole, Miconazole, Amphotericin B, and Nystatin) antibiotics were used as positive controls. Macro broth tube test was run to determine Minimum Inhibitory Concentration (MIC). The findings indicated that linolenic acid, methyl ester was the most frequent constituent found in A. Saralicum. Indeed, A. Saralicum showed higher antibacterial and antifungal properties than all standard antibiotics (pâ¯≤â¯.01). Also, A. Saralicum prevented the growth of all bacteria and fungi at 15-125â¯mg/mL concentrations and destroyed them at 15-250â¯mg/mL concentrations (pâ¯≤â¯.01). DPPH free radical scavenging test was carried out to examine the antioxidant effect, which indicated similar antioxidant activity with butylated hydroxy toluene (BHT) as a positive control. The synthesized ethanolic extract had great cell viability dose-dependently and demonstrated this method was nontoxic for synthesizing A. Saralicum. In conclusion, the findings showed the useful antioxidant, non-cytotoxic, antibacterial, and antifungal effects of A. Saralicum ethanolic extract.
